心脏不良改造的分期在中度或重度大动脉反中
Maan Malahfji1, Duc T Nguyen2, Priyanka Bhugra1
1Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA.
JACC. Cardiovascular imaging
|August 4, 2025
概括
使用心脏磁共振 (CMR) 的新型心脏重塑分期系统有效预测大动脉吐 (AR) 患者的死亡率. 右心脏重塑表明死亡风险最高,这表明治疗决策的指导潜力.
科学领域:
- 心脏病学 心脏病学
- 心血管成像 - 心血管成像
- 医学诊断 医学诊断 医学诊断
背景情况:
- 大动脉反 (AR) 是一种重要的心血管疾病.
- 准确的预后对于管理中度至重度的AR至关重要.
- 现有的分期系统在其他膜疾病中具有预后价值.
研究的目的:
- 研究一种用于中度或重度大动脉反 (AR) 的心脏结构和功能异常的新型分期系统.
- 将心脏磁共振 (CMR) 发现纳入分期系统.
- 评估这种基于CMR的分期系统对所有原因死亡的预后价值.
主要方法:
- 预期在DEBAKEY-CMR研究中招募中度或重度AR患者.
- 排除患有原发性心肌病或先前门干预的患者.
- 基于心脏改造的阶段定义:第0阶段 (没有改造),第1阶段 (LV改造),第2阶段 (心心/左心房异常),第3阶段 (右心脏改造).
主要成果:
- 研究了395名患者,35.4%被归类为第三阶段 (右心脏重塑).
- 年化死亡率随阶段显著增加 (0.68%在0阶段至7.25%在3阶段;P<0.001).
- 心脏重塑程度与死亡风险增加独立相关 (aHR为每阶段增量1.69),右心脏重塑显示的风险最高.
结论:
- 基于CMR的心脏重塑分期系统在AR中提供了增量预后价值.
- 阶段系统提供了预后信息,不仅仅是吐严重程度,AVR和手术风险得分.
- 在AR中右心脏重塑与死亡率增加密切相关,突出其临床意义.
相关概念视频
01:15Aortic Regurgitation I: Introduction
37
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
37
01:25Aortic Regurgitation III: Medical Management
43
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
43
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
52
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52
01:17Aortic Regurgitation IV: Nursing Management
55
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
55
01:20Mitral Regurgitation I: Introduction
56
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
56
01:25Mitral Regurgitation III: Medical Management
30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30